Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrance G Johns

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|September 19, 2022
ErbB4 in the brain: Focus on high grade gliomaJamie-Lee Pitcher, Naomi Alexander, Panimaya Jeffreena Miranda, et al.
Sarcoma|November 9, 2016
Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid LiposarcomaLauren T Kerr, Jacqueline F Donoghue, Alexander L Wilding, et al.
Ecology and Evolution|October 23, 2024
Lemming and Vole Cycles: A New Intrinsic ModelElizabeth A Levay, Helen Nasser, Matthew D Zelko, et al.
Journal of Visualized Experiments : Jove|August 18, 2020
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant TherapiesFrancois X Rwandamuriye, Breana J Weston, Terrance G Johns, et al.
Neoplasia (New York, N.Y.)|March 26, 2018
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain TumorsRaelene Endersby, Jacqueline Whitehouse, Hilary Hii, et al.
Journal of Cellular and Molecular Medicine|May 13, 2009
Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalizationHui K Gan, Martha Lappas, Diana X Cao, et al.
The Journal of Biological Chemistry|November 10, 2006
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806Hui K Gan, Francesca Walker, Antony W Burgess, et al.
Circulation Research|April 26, 2008
Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodelingHua Zhang, Susan W Sunnarborg, K Kirk McNaughton, et al.
Signal Transduction and Targeted Therapy|October 19, 2023
From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progressBrittany Dewdney, Misty R Jenkins, Sarah A Best, et al.
Hybridoma and Hybridomics|September 27, 2003
Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analysesZhanqi Liu, Con Panousis, Fiona E Smyth, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|September 19, 2022
ErbB4 in the brain: Focus on high grade gliomaJamie-Lee Pitcher, Naomi Alexander, Panimaya Jeffreena Miranda, et al.
Sarcoma|November 9, 2016
Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid LiposarcomaLauren T Kerr, Jacqueline F Donoghue, Alexander L Wilding, et al.
Ecology and Evolution|October 23, 2024
Lemming and Vole Cycles: A New Intrinsic ModelElizabeth A Levay, Helen Nasser, Matthew D Zelko, et al.
Journal of Visualized Experiments : Jove|August 18, 2020
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant TherapiesFrancois X Rwandamuriye, Breana J Weston, Terrance G Johns, et al.
Neoplasia (New York, N.Y.)|March 26, 2018
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain TumorsRaelene Endersby, Jacqueline Whitehouse, Hilary Hii, et al.
Journal of Cellular and Molecular Medicine|May 13, 2009
Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalizationHui K Gan, Martha Lappas, Diana X Cao, et al.
The Journal of Biological Chemistry|November 10, 2006
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806Hui K Gan, Francesca Walker, Antony W Burgess, et al.
Circulation Research|April 26, 2008
Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodelingHua Zhang, Susan W Sunnarborg, K Kirk McNaughton, et al.
Signal Transduction and Targeted Therapy|October 19, 2023
From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progressBrittany Dewdney, Misty R Jenkins, Sarah A Best, et al.
Hybridoma and Hybridomics|September 27, 2003
Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analysesZhanqi Liu, Con Panousis, Fiona E Smyth, et al.
Pageof 9